G T Stevenson1, V A Anderson, W S Leong
1Tenovus Research Laboratory, Southampton General Hospital, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Altering antibody structure enhances cancer treatment efficacy by improving effector cell recruitment and antibody persistence. Modified antibodies, like bispecific variants, offer potent anti-tumor activity against lymphomas and other cancers.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: